2O TILs and PD-L1 Early Dynamics in the Randomized Neo-CheckRay Phase II Trial Evaluating Neo-Adjuvant Immuno-Radiation and Adenosine Pathway Blockade for Early-Stage, High Risk ER+/HER2- Breast Cancer (BC)
Immuno-Oncology and Technology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined